Form 4 for ANRO Alto Neuroscience, Inc.
Accepted 2024-04-01 00:00:00 ET · period of report 2024-03-28 · accession 0001415889-24-009533 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-04-01 | 2024-03-28 | ANRO | Smith Nicholas Conrad | CFO | P - Purchase | $16.36 | +6,150 | 26.9K | +30% | +$100.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-28 | P | A | 1,600 | $15.80 | 22,316 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-28 | P | A | 4,550 | $16.56 | 26,866 | D | — | — |